David Einhorn - DME Capital Management,
Holding/activity history for Nuvation Bio Inc. (NUVB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 34,995 | <0.01 | $4.29 | $150,129 | SEC | ||
| 2025 Q4 | 34,995 | 0.01 | $8.96 | $313,555 | SEC | ||
| 2025 Q3 | 34,995 | 0.01 | $3.70 | $129,482 | SEC | ||
| 2025 Q2 | 34,995 | <0.01 | $1.95 | $68,240 | SEC | ||
| 2025 Q1 | 34,995 | <0.01 | $1.76 | $61,591 | SEC | ||
| 2024 Q4 | 34,995 | <0.01 | $2.66 | $93,087 | SEC | ||
| 2024 Q3 | 34,995 | <0.01 | $2.29 | $80,139 | SEC | ||
| 2024 Q2 | 34,995 | <0.01 | $2.92 | $102,185 | SEC | ||
| 2024 Q1 | 34,995 | 0.01 | $3.64 | $127,382 | SEC |